Biohellenika offers a new stem cell collection and storage service from cord blood, the VSELs, after a long-term effort by its Research and Development Department. Thus, the company overcomes the storage of whole cord blood, which aims to maintain VSELs, and offers the storage of VSELs as an independent service, ready for use.
The cord blood except the hematopoietic stem cells, contains another more primitive cell population, the second in hierarchy during evolution, that is named Very Small Embryonic Like Stem cells-VSELs). These cells are very small in size and because of that, using the conventional protocols they were lost during the hematopoietic collection. VSELs are suitable only for the child (autologous use) and this is one of the privileges that offers, among others, the private cord blood banking. From this cell population different cell lines were created in order to use for tissue and organ regeneration, in the case of their failure. Their presence in the cord blood gives new perspective in Regenerative Medicine beyond of hematology. Until now from VSELs created cardiomyocytes, lung covering epithelium, oocytes and sperm and in co culture with cord tissue mesenchymal stem cells they produce hematopoietic stem cells very useful in hematopoietic transplantations.
VSELs are a new stem cell population in the cord blood, but the most primitive, and may be is the missing puzzle in cellular therapies.
Dear Parents
Today 7/3/2018 Biohellenika completed 12 years of operation. With patience, commitment, focus and hard work we expand Biohellenika in Asia and in one month our lab in Manila, Philippines, will accept the first cord blood samples for cryopreservation. Our plans are during the year to transfer our expertise in a new lab in Jakarta, Indonesia.
Today, Biohellenika, with its own funding, is located in 10 countries around the world, overcoming the Greek borders and the economic problems created by the financial crisis.
We invest in our Research and Development Department, create innovative products that we promote in foreign markets, contributing to the national economy.
The operation of Biohellenika is our main job that we have learned and been practiced during the 38 years of our medical and academic career.
We continue the tradition of 4th generation in Medicine and hope to be with you by our physical presence for many years.
The Chairman and Chief Executive Officer of Biohellenika
George Kolιakos
Professor of Medicine
Treatment of cerebral palsy with autologous cord blood stem cells seems very promising in children that born with oxygen depletion. The study is contated by Prof J Kurtzberg, in Duke University. Actually there are many studies in progress in this Clinic. In thses studies are participating newborns to 10 years old with difficulties in perinatal oxygenation. In summary, cell dose, the age of the child and repeating treatments are the factors that improve the clinical condition of the child.
Βiohellenika congratulates the President and CEO, Prof Koliakos George for the honors received by the Medical School of Aristotelian University Thessaloniki Greece, because in 2017 he received the most important national and international distinctions in science, which honored the Medical School in Greece and abroad.
Staff of Biohellenika SA
Biohellenika successfully renewed the ESYD accreditation
Biohellenika has been rated for the 10th time by ESYD (National Accreditation System) and has successfully renewed its accreditation. The accreditation concerns all the tests carried out in its laboratories and concerns all the stages of processing and storing the stem cells. The current audit was fully in line with the requirements of Ministerial Decision 18092 of 24/3/2017 on the terms and conditions for the operation of Umbilical Cord Blood Banks.
Biohellenika has all the necessary equipment in multiple, facilities and accreditations and has the flexibility to automatically adapt to any requirements if requested. The lab has been implementing quality systems since 2006 and today it has a high level of reliability and maturity.
Biohellenika thanks and congratulates the staff for the outstanding performance during the inspection, due to the education, responsibility and long stay in the company.
Koliakos George
CEO and President of Biohellenika
Professor of Medicine
Stem Cells Bank Biohellenika - Web design Hexabit - W3C - Pagespeed